FDMT logo

FDMT EBITDA

Annual EBITDA

-$181.14 M
-$74.02 M-69.10%

December 1, 2024


Summary


Performance

FDMT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTprofitabilitymetrics:

Quarterly EBITDA

-$54.33 M
-$4.90 M-9.92%

December 1, 2024


Summary


Performance

FDMT Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTprofitabilitymetrics:

TTM EBITDA

-$181.14 M
-$19.19 M-11.85%

December 1, 2024


Summary


Performance

FDMT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

FDMT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-69.1%-33.1%-44.8%
3 y3 years-165.2%-332.0%-82.4%
5 y5 years-305.9%-332.0%-82.4%

FDMT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-165.2%at low-332.0%at low-165.2%at low
5 y5-year-305.9%at low-692.7%at low-556.9%at low
alltimeall time-1767.0%at low-692.7%at low-1460.7%at low

4D Molecular Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$181.14 M(+69.1%)
-$54.33 M(+9.9%)
-$181.14 M(+11.9%)
Sep 2024
-
-$49.43 M(+21.1%)
-$161.94 M(+29.5%)
Jun 2024
-
-$40.83 M(+11.7%)
-$125.09 M(+8.8%)
Mar 2024
-
-$36.54 M(+4.0%)
-$114.97 M(+7.3%)
Dec 2023
-$107.12 M(+0.9%)
-$35.14 M(+179.4%)
-$107.12 M(+7.9%)
Sep 2023
-
-$12.58 M(-59.0%)
-$99.31 M(-11.6%)
Jun 2023
-
-$30.71 M(+7.0%)
-$112.35 M(+2.8%)
Mar 2023
-
-$28.69 M(+5.0%)
-$109.24 M(+2.9%)
Dec 2022
-$106.15 M(+55.4%)
-$27.33 M(+6.7%)
-$106.15 M(+3.2%)
Sep 2022
-
-$25.62 M(-7.2%)
-$102.81 M(+3.7%)
Jun 2022
-
-$27.59 M(+7.8%)
-$99.10 M(+26.5%)
Mar 2022
-
-$25.61 M(+6.7%)
-$78.36 M(+14.7%)
DateAnnualQuarterlyTTM
Dec 2021
-$68.31 M(+23.7%)
-$23.99 M(+9.6%)
-$68.31 M(+6.1%)
Sep 2021
-
-$21.90 M(+219.5%)
-$64.37 M(+29.0%)
Jun 2021
-
-$6.85 M(-56.0%)
-$49.92 M(-13.7%)
Mar 2021
-
-$15.56 M(-22.4%)
-$57.85 M(+4.8%)
Dec 2020
-$55.22 M(+23.8%)
-$20.05 M(+169.2%)
-$55.22 M(+8.0%)
Sep 2020
-
-$7.45 M(-49.6%)
-$51.14 M(-7.5%)
Jun 2020
-
-$14.79 M(+14.4%)
-$55.30 M(+36.5%)
Mar 2020
-
-$12.93 M(-19.0%)
-$40.51 M(+46.9%)
Dec 2019
-$44.62 M(+359.9%)
-$15.97 M(+37.6%)
-$27.58 M(+137.6%)
Sep 2019
-
-$11.61 M
-$11.61 M
Dec 2018
-$9.70 M(-8.9%)
-
-
Dec 2017
-$10.65 M
-
-

FAQ

  • What is 4D Molecular Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics annual EBITDA year-on-year change?
  • What is 4D Molecular Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics quarterly EBITDA year-on-year change?
  • What is 4D Molecular Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics TTM EBITDA year-on-year change?

What is 4D Molecular Therapeutics annual EBITDA?

The current annual EBITDA of FDMT is -$181.14 M

What is the all time high annual EBITDA for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high annual EBITDA is -$9.70 M

What is 4D Molecular Therapeutics annual EBITDA year-on-year change?

Over the past year, FDMT annual EBITDA has changed by -$74.02 M (-69.10%)

What is 4D Molecular Therapeutics quarterly EBITDA?

The current quarterly EBITDA of FDMT is -$54.33 M

What is the all time high quarterly EBITDA for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high quarterly EBITDA is -$6.85 M

What is 4D Molecular Therapeutics quarterly EBITDA year-on-year change?

Over the past year, FDMT quarterly EBITDA has changed by -$13.50 M (-33.06%)

What is 4D Molecular Therapeutics TTM EBITDA?

The current TTM EBITDA of FDMT is -$181.14 M

What is the all time high TTM EBITDA for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high TTM EBITDA is -$11.61 M

What is 4D Molecular Therapeutics TTM EBITDA year-on-year change?

Over the past year, FDMT TTM EBITDA has changed by -$56.05 M (-44.80%)